ロード中...
COVID-19: Antiviral agents and enzyme inhibitors/receptor blockers in development
Novel 2019 coronavirus (severe acute respiratory syndrome coronavirus 2 [SARS-CoV-2]) and coronavirus disease 2019 (COVID-19), the respiratory syndrome it causes, have shaken the world to its core by infecting and claiming the lives of many people since originating in December 2019 in Wuhan, China....
保存先:
| 出版年: | Exp Biol Med (Maywood) |
|---|---|
| 主要な著者: | , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
SAGE Publications
2021
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8283249/ https://ncbi.nlm.nih.gov/pubmed/33757336 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1535370221999989 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|